Neurofibromatosis

被引:104
作者
McClatchey, Andrea I. [1 ]
机构
[1] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA
[2] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
关键词
peripheral nerve sheath tumor; schwannoma; neurofibromin; Ras signaling; merlin/schwannomin; ezrin; radixin; moesin (the ERM proteins); membrane organization;
D O I
10.1146/annurev.pathol.2.010506.091940
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
As familial cancer syndromes, the neurofibromatoses exhibit complex phenotypes, comprising a range of tumor and nontumor manifestations. Although the three recognized forms of neurofibromatosis NF1, NF2, and schwannomatosis) all feature the development of nervous system rumors, their underlying genetic bases are clearly distinct. The most prominent common feature of all three is the appearance of Schwann cell-initiated tumorigenesis of the peripheral nervous system. Recent progress in delineating the molecular function of the NF1- and NF2-encoded proteins, together with the development and use of manipulable mouse models, has led to important advances in understanding the pathogenesis of many features of neurofibromatosis. An important outcome of the study of neurofibromatosis-associated tumorigenesis has been insight into the more general molecular and cellular bases of nervous system rumors.
引用
收藏
页码:191 / 216
页数:26
相关论文
共 155 条
[81]   Diagnostic criteria for schwannomatosis [J].
MacCollin, M ;
Chiocca, EA ;
Evans, DG ;
Friedman, JM ;
Horvitz, R ;
Jaramillo, D ;
Lev, M ;
Mautner, VF ;
Niimura, M ;
Plotkin, SR ;
Sang, CN ;
Stemmer-Rachamimov, A ;
Roach, ES .
NEUROLOGY, 2005, 64 (11) :1838-1845
[82]   Familial schwannomatosis - Exclusion of the NF2 locus as the germline event [J].
MacCollin, M ;
Willett, C ;
Heinrich, B ;
Jacoby, LB ;
Acierno, JS ;
Perry, A ;
Louis, DN .
NEUROLOGY, 2003, 60 (12) :1968-1974
[83]   Expression level, subcellular distribution and Rho-GDI binding affinity of merlin in comparison with ezrin/radixin/moesin proteins [J].
Maeda, M ;
Matsui, T ;
Imamura, M ;
Tsukita, S ;
Tsukita, S .
ONCOGENE, 1999, 18 (34) :4788-4797
[84]   In vitro and in vivo effects of a farnesyltransferase inhibitor on Nf1-deficient hematopoietic cells [J].
Mahgoub, N ;
Taylor, BR ;
Gratiot, M ;
Kohl, NE ;
Gibbs, JB ;
Jacks, T ;
Shannon, KM .
BLOOD, 1999, 94 (07) :2469-2476
[85]   The tumor suppressors merlin and expanded function cooperatively to modulate receptor endocytosis and signaling [J].
Maitra, S ;
Kulikauskas, RM ;
Gavilan, H ;
Fehon, RG .
CURRENT BIOLOGY, 2006, 16 (07) :702-709
[86]  
McCarthy A M, 1996, J Pediatr Oncol Nurs, V13, P3
[87]  
McCartney BM, 2000, DEVELOPMENT, V127, P1315
[88]   Membrane organization and tumorigenesis - the NF2 tumor suppressor, Merlin [J].
McClatchey, AI ;
Giovannini, M .
GENES & DEVELOPMENT, 2005, 19 (19) :2265-2277
[89]   The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation [J].
McClatchey, AI ;
Saotome, I ;
Ramesh, V ;
Gusella, JF ;
Jacks, T .
GENES & DEVELOPMENT, 1997, 11 (10) :1253-1265
[90]   Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors [J].
McClatchey, AI ;
Saotome, I ;
Mercer, K ;
Crowley, D ;
Gusella, JF ;
Bronson, RT ;
Jacks, T .
GENES & DEVELOPMENT, 1998, 12 (08) :1121-1133